Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

03/06/19GBT Announces New Employment Inducement Grants
03/04/19GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference
02/27/19GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results
02/21/19GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference

More »

Media Resources

Stay Informed

Sign up to receive email updates about ongoing sickle cell disease clinical studies, awareness and educational information and GBT news at:

Media Contact

Stephanie Yao